Deborah Gerard

Esch-sur-alzette, ES, Luxembourg

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

EpiATLAS - a reference for human epigenomic research.

EpiATLAS - a reference for human epigenomic research.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

Epigenetic control of metabolic identity across cell types.

Epigenetic control of metabolic identity across cell types.

Journal: BMC genomics
Published: August 06, 2025

ZFHX4 is necessary for dopaminergic neuron differentiation and controls cell cycle by regulating LIN28A.

ZFHX4 is necessary for dopaminergic neuron differentiation and controls cell cycle by regulating LIN28A.

Journal: Stem cell reports
Published: July 28, 2025

Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1.

Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1.

Journal: Frontiers in oncology
Published: December 21, 2024

Epigenetic control of metabolic identity across cell types.

Epigenetic control of metabolic identity across cell types.

Journal: bioRxiv : the preprint server for biology
Published: August 02, 2024

ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides.

ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides.

Journal: Leukemia
Published: March 20, 2023

Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions.

Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions.

Journal: Cell reports
Published: April 05, 2022

ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous Melanoma and Regulated by NRF1.

ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous Melanoma and Regulated by NRF1.

Journal: Frontiers in oncology
Published: June 07, 2021

Assessment of Mitochondrial Cell Metabolism by Respiratory Chain Electron Flow Assays.

Assessment of Mitochondrial Cell Metabolism by Respiratory Chain Electron Flow Assays.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 01, 2021

The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia.

The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia.

Journal: Pharmacological research
Published: November 10, 2019

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.

Journal: Clinical epigenetics
Published: October 25, 2019

Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia.

Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia.

Journal: Cell death & disease
Published: October 11, 2019
Showing 1-12 of 19

Last Updated: 09/26/2026